This site is intended for healthcare professionals only

This site is intended for healthcare professionals and relevant decision makers.

THElifeSCIENCE

About Us Contact Us

© 2025 - 2026

The Life Science Feed. All rights reserved.

A digital publication from Grá & Mawi Media Co.

THE life SCIENCE

Cardiology
Dentistry
Endocrinology
General Practice
Haematology
Infectious Diseases
Obstetrics & Gyn
Oncology
Pediatrics
Pulmonology

•

Aortic Valve Stenosis
Breast Neoplasms
Chronic Kidney Disease
Congenital Heart Defects
Coronary Artery Disease
Fatty Liver
Heart Failure
Infertility Female
Myocardial Infarction
Obesity

•

Case
Guidelines
Innovation
Insights
News
Policy
Practice
Research

THE life SCIENCE

Trusted medical news for healthcare professionals

Tuesday, 5 May 2026

Today on The Life Science Feed

All Cardiology Oncology Endocrinology Neurology Nephrology Pulmonology Gastroenterology Rheumatology Hepatology Psychiatry Infectious Haematology Immunology Dermatology Pediatrics Geriatrics Rare Diseases General Practice

Category

guidelines

Loading articles...

THE life SCIENCE FEED

Evidence-based clinical insights for healthcare professionals.

About Us

About
Editorial Policy
AI Disclaimer
Contact Us
Advertise With Us

Therapy Areas

Cardiology
Oncology
Neurology
Endocrinology
Pulmonology

Newsletters

General Newsletter
Cardiology Pulse
Oncology Brief

Legal

Privacy Policy
Terms & Conditions
Cookie Policy
Accessibility
Copyright

OUR PARTNERS:

THE life SCIENCE

Accessibility
Advertising Policy
AI Disclaimer
Community Standards
Cookie Information
Copyright
Modern Slavery Statement
Privacy Policy
Terms & Conditions

© 2025 - 2026 The Life Science Feed. All rights reserved. A digital publication from Grá & Mawi Media Co.

CategoryDisease areaKeyword

JAK Inhibitors in RA: 2025 EULAR Safety Update Redraws Risk Guidance
The 2025 EULAR RA update revises JAK inhibitor safety guidance, with implications for prescribing in higher-risk patients.
ART-2026-001
Read more